Press release
Guillain Barre Syndrome Treatment Market Size, Share, Analysis, Industry Report and Forecast 2022-2028
The global Guillain barre syndrome treatment market is anticipated to grow at a significant CAGR of 5.2% during the forecast period 2022-2028. As per the information provided by the United Nations, in 2020, there are an estimated 727 million persons aged 65 years or over across. Additionally, this number is projected to be more than double by 2050, reaching over 1.5 billion persons. So, the increasing elderly population, which leads to the pervasiveness of immunological illnesses is one of the primary factors driving the expansion of the guillain barre syndrome market.To Request a Sample of our Report on Guillain Barre Syndrome Treatment Market: https://www.omrglobal.com/request-sample/guillain-barre-syndrome-treatment-market
Further, the key players operating in the global guillain barre syndrome treatment market had been adopting strategies such as new launches and agreements to gain major market share. For instance, in November 2021, Biotest AG announced the authorization in France for the human intravenous immunoglobulin preparation that is Intratect which is manufactured and marketed by Biotest in two concentrations. The Intratect is an important component of Biotest's portfolio with over 50 approvals globally. The broad spectrum of indications includes substitution therapy for primary and secondary immunodeficiency diseases along with immunomodulation for primary immune thrombocytopenia, Guillain-Barré syndrome, and Kawasaki syndrome, among others. Further, in September 2019, Annexon Biosciences Inc., announced that the FDA had granted fast track designation to ANX005, a novel treatment for Guillain-Barré syndrome. ANX005 is a clinical-stage investigational monoclonal antibody intended to treat patients with autoimmune and neurodegenerative disorders and formulated for IV administration.
Market Coverage
· The market number available for - 2021-2028
· Base year- 2021
· Forecast period- 2022-2028
Segment Covered-
· By Type
· By Distribution Channel
Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
Competitive Landscape - including, Bayer AG, Grifols SA, CSL Ltd., Octapharma AG, Kedrion Biopharma Inc., and Takeda Pharmaceutical Co. Ltd., among others.
(Get 15% Discount on Buying this Report)
A full Report of Guillain Barre Syndrome Treatment Market is Available @ https://www.omrglobal.com/industry-reports/guillain-barre-syndrome-treatment-market
Global Guillain Barre Syndrome Treatment Market Report Segment
By Type
· Intravenous Immunoglobulin
· Plasma Exchange
· Others (Anticonvulsants and LMWH)
By Distribution Channel
· Hospital Pharmacy
· Retail Pharmacy
· Others
Global Guillain Barre Syndrome Treatment Market Report Segment by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Company Profiles
· Akari Therapeutics Inc.
· Annexon Biosciences Inc.
· Bayer AG
· Biotest AG
· China Biologic Product Holdings Inc.
· CSL Ltd.
· CuraVac Inc.
· Grifols SA
· Hansa Medical AB
· Kedrion Biopharma Inc.
· Nihon Pharmaceutical Co. Ltd.
· Octapharma AG
· Takeda Pharmaceutical Co. Ltd.
· Vitality Biopharma Inc.
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Guillain Barre Syndrome Treatment Market Size, Share, Analysis, Industry Report and Forecast 2022-2028 here
News-ID: 2601813 • Views: …
More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033.
Infrastructure as Code (IaC) Service Market Overview
The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market…

Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033.
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview
The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,…

Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033.
Property Management Service Market Overview
The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly…

5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033.
5G Chipset Market Overview
The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT…
More Releases for Guillain
Guillain-Barré Syndrome Market Insights and Future Outlook
Introduction
Guillain-Barré Syndrome (GBS) is a rare but serious autoimmune neurological disorder in which the body's immune system mistakenly attacks the peripheral nervous system, leading to muscle weakness, sensory loss, and in severe cases, paralysis. The condition often follows infections such as influenza, Campylobacter, or viral illnesses, and has also been reported after certain vaccinations.
While most patients recover fully with appropriate treatment, GBS can be life-threatening without timely intervention, particularly when…
Personalized Medicine Drives Guillain-Barre Syndrome Drugs Market Growth Driving …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Guillain-Barre Syndrome Drugs Market Size By 2025?
The market size for drugs addressing guillain-barre syndrome has seen considerable growth in the past few years. The growth trajectory is set to continue and expand from $1.17 billion in 2024 to $1.26 billion in 2025, marking a…
Emerging Trends Influencing The Growth Of The Guillain-Barre Syndrome Drugs Mark …
The Guillain-Barre Syndrome Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Guillain-Barre Syndrome Drugs Market Size Expected to Be by 2034?
The guillain-barré syndrome drugs market has seen strong growth in recent years. It will increase from $1.17 billion in 2024…
Prominent Guillain-Barre Syndrome Drugs Market Trend for 2025: Innovative Humani …
How Are the key drivers contributing to the expansion of the guillain-barre syndrome drugs market?
The growing demand for personalized medicine is anticipated to drive the expansion of the Guillain-Barré syndrome drugs market. Personalized medicine customizes treatments based on individual factors like genetics and lifestyle to enhance effectiveness and reduce side effects. This demand is growing due to advancements in genomics, increasing disease complexity, and supportive regulations. For example, in February…
Top Factor Driving Guillain-Barre Syndrome Drugs Market Growth in 2025: Personal …
How Big Is the Guillain-Barre Syndrome Drugs Market Expected to Be, and What Will Its Growth Rate Be?
The market for drugs treating Guillain-Barre syndrome has seen robust expansion in the recent past. This growth trend is projected to continue, with the market size expected to increase from $1.17 billion in 2024 to $1.26 billion in 2025, witnessing a compound annual growth rate (CAGR) of 8.2%. This growth trajectory in the…
Guillain-Barre Syndrome (GBS) Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "Guillain-Barre Syndrome (GBS) Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly studies…